Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases

American Journal of Surgical Pathology

Volumn 33, Issue 12, 2009, Pages 1752-1764

  Girard, Nicolas ^a   Deshpande, Charuhas ^b   Lau, Christopher ^b   Finley, David ^b   Rusch, Valerie ^b   Pao, William ^a,b,c,d   Travis, William D ^b  

^a Human Oncology and Pathogenesis Program   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; FROZEN SECTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METASTASIS; MULTIPLE CANCER; MUTATION; PATHOLOGY; PREDICTION AND FORECASTING; SQUAMOUS CELL CARCINOMA; TIME; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FROZEN SECTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MUTATION; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 73349092440     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181b8cf03     Document Type: Article

References (21)

1. Braakhuis BJ, Tabor MP, Leemans CR, et al. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck. 2002;24:198-206.
2. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455:1069-1075.
3. Gabrielson E. Worldwide trends in lung cancer pathology. Respirology. 2006;11:533-538.
4. Girard N, Ostrovnaya I, Lau C, et al. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers. Clin Cancer Res. 2009;15:5184-5190.
5. Inamura K, Takeuchi K, Togashi Y, et al. EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers. J Thorac Oncol. 2008;3:13-17.
6. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606-612.
7. Miyoshi T, Satoh Y, Okumura S, et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol. 2003;27:101-109.
8. Moro-Sibilot D, Lantuejoul S, Diab S, et al. Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis. Eur Respir J. 2008;31:854-859.
9. Motoi N, Szoke J, Riely GJ, et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol. 2008;32:810-827.
10. Nakano H, Soda H, Nakamura Y, et al. Different epidermal growth factor receptor gene mutations in a patient with 2 synchronous lung cancers. Clin Lung Cancer. 2007;8:562-564. (Pubitemid 350292230)
11. Oliaro A, Filosso PL, Cavallo A, et al. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system. Eur J Cardiothorac Surg. 2008;34:438-443.
12. Ostrovnaya I, Olshen AB, Seshan VE, et al. Metastasis or a Second Independent Cancer? Evaluating the Clonal Origin of Tumors Using Array Comparative Genomic Hybridization Data Available at http://www.bepress.com/ mskccbiostat/paper15/
13. Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA. 2004;101:13306-13311.
14. Rice D, Kim HW, Sabichi A, et al. The risk of second primary tumors after resection of stage I non-small cell lung cancer. Ann Thorac Surg. 2003;76:1001-1007.
15. Riquet M, Cazes A, Pfeuty K, et al. Multiple lung cancers prognosis: what about histology? Ann Thorac Surg. 2008;86:921-926.
16. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer. 1995; 75:191-202.
17. Trousse D, Barlesi F, Loundou A, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg. 2007; 133:1193-1200.
18. Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 2007;450:893-898.
19. Weiss MM, Kuipers EJ, Meuwissen SG, et al. Comparative genomic hybridisation as a supportive tool in diagnostic pathology. J Clin Pathol. 2003;56:522-527.
20. World Health Organization. WHO histological classification of tumours of the lung. In: Travis WB, Brambilla A, Muller-Hermelinck HK, et al, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004:10.
21. World Health Organization. Histological Typing of Lung Tumours. Geneva, Switzerland: World Health Organization; 1967